Darren R Feldman

Darren R Feldman

UNVERIFIED PROFILE

Are you Darren R Feldman?   Register this Author

Register author
Darren R Feldman

Darren R Feldman

Publications by authors named "Darren R Feldman"

Are you Darren R Feldman?   Register this Author

100Publications

2466Reads

23Profile Views

Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.

J Clin Oncol 2019 Sep 24;37(26):2329-2337. Epub 2019 Jun 24.

Memorial Sloan Kettering Cancer Center, New York, NY and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.01608DOI Listing
September 2019

Altering the Natural History of Surgical Relapse in Testicular Cancer: Suboptimal Surgery and Pneumoperitoneum.

Eur Urol 2019 Jul 18. Epub 2019 Jul 18.

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.07.016DOI Listing
July 2019

High-dose radiation therapy is needed for intracranial control and long-term survival in patients with non-seminomatous germ cell tumor brain metastases.

J Neurooncol 2019 May 15;142(3):523-528. Epub 2019 Feb 15.

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03123-0DOI Listing
May 2019

Testicular cancer.

Nat Rev Dis Primers 2018 10 5;4(1):29. Epub 2018 Oct 5.

Department of Pathology, Josephine Nefkens Building, Erasmus MC-University Medical Center, Cancer Institute, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41572-018-0029-0DOI Listing
October 2018

Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.

J Clin Oncol 2018 05 4;36(15):1505-1512. Epub 2018 Apr 4.

Sarah L. Kerns, Chunkit Fung, AnnaLynn M. Williams, and Deepak M. Sahasrabudhe, University of Rochester Medical Center, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Patrick O. Monahan, Shirin Ardeshir-Rouhani-Fard, Mohammad I. Abu Zaid, Timothy E. Stump, Ryan Cook, Lawrence H. Einhorn, and Lois B. Travis, Indiana University, Indianapolis, IN; Howard D. Sesso, Brigham and Women's Hospital; Clair Beard, Dana-Farber Cancer Institute, Boston, MA; Robert J. Hamilton, Princess Margaret Cancer Centre, Toronto, Ontario; Christian Kollmannsberger, University of British Columbia, Vancouver, British Columbia, Canada; David J. Vaughn, University of Pennsylvania, Philadelphia, PA; Robert A. Huddart, The Royal Marsden Hospital, London, United Kingdom; Jeri Kim, MD Anderson Cancer Center, Houston, TX; and Sophie D. Fossa, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.0735DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959198PMC
May 2018

Hearing Loss in Adult Survivors of Childhood Cancer Treated with Radiotherapy.

Children (Basel) 2018 May 4;5(5). Epub 2018 May 4.

Memorial Sloan Kettering Adult Long-Term Follow-Up Program, 485 Lexington Ave, 2nd Floor, New York, NY 10017, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/children5050059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977041PMC
May 2018

State-of-the-Art Management of Germ Cell Tumors.

Authors:
Darren R Feldman

Am Soc Clin Oncol Educ Book 2018 May;38:319-323

From the Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill-Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_201139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607431PMC
May 2018

Controversies in the Management of Clinical Stage I Seminoma: Carboplatin a Decade in-Time to Start Backing Out.

J Clin Oncol 2018 03 1;36(9):837-840. Epub 2018 Feb 1.

Rune A.W. van de Wetering and Stefan Sleijfer, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Darren R. Feldman, Samuel A. Funt, and George J. Bosl, Memorial Sloan Kettering Cancer Center, New York, NY; and Ronald de Wit, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.5610DOI Listing
March 2018

Conventional-Dose versus High-Dose Chemotherapy for Relapsed Germ Cell Tumors.

Adv Urol 2018 15;2018:7272541. Epub 2018 Mar 15.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/7272541DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874975PMC
March 2018

Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm.

J Clin Oncol 2017 11 30;35(31):3525-3528. Epub 2017 Aug 30.

Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Christian K. Kollmannsberger, University of British Columbia, Vancouver, British Columbia, Canada; Bruce J. Roth, Washington University School of Medicine, St Louis, MO; Claudio Jeldres, Sherbrooke University, Sherbrooke, Quebec, Canada; Silke Gillessen, Kantonsspital, St Gallen, Switzerland; Karim Fizazi, University of Paris Sud, Paris, France; Siamak Daneshmand, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA; William T. Lowrance, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Nasser H. Hanna, Indiana University School of Medicine, Indianapolis, IN; Gabriella Cohn Cedermark, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden; Darren R. Feldman, Memorial Sloan Kettering Cancer Center and Weill Medical Cornell Medical College, New York, NY; Thomas Powles, Barts Cancer Institute, St Bartholomew's Hospital, Queen Mary University of London, London, United Kingdom; Mark A. Lewis, Intermountain Health, Salt Lake City, UT; Peter Scott Grimison, University of Sydney, Sydney, New South Wales, Australia; Douglas Bank, Testicular Cancer Resource Center, Riverwoods, IL; Christopher Porter, Virginia Mason Medical Center, Seattle, WA; Peter Albers, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany; Maria De Santis, Cancer Research Center, University of Warwick, Coventry, United Kingdom; Sandy Srinivas, Stanford University School of Medicine, Stanford, CA; George J. Bosl, Memorial Sloan Kettering Cancer Center, New York, NY; and Craig R. Nichols, Precision Genomics Cancer Research Clinic, Intermountain Health, Salt Lake City, UT; Testicular Cancer Commons, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.4723DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791831PMC
November 2017

Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

Authors:
Ahmet Zehir Ryma Benayed Ronak H Shah Aijazuddin Syed Sumit Middha Hyunjae R Kim Preethi Srinivasan Jianjiong Gao Debyani Chakravarty Sean M Devlin Matthew D Hellmann David A Barron Alison M Schram Meera Hameed Snjezana Dogan Dara S Ross Jaclyn F Hechtman Deborah F DeLair JinJuan Yao Diana L Mandelker Donavan T Cheng Raghu Chandramohan Abhinita S Mohanty Ryan N Ptashkin Gowtham Jayakumaran Meera Prasad Mustafa H Syed Anoop Balakrishnan Rema Zhen Y Liu Khedoudja Nafa Laetitia Borsu Justyna Sadowska Jacklyn Casanova Ruben Bacares Iwona J Kiecka Anna Razumova Julie B Son Lisa Stewart Tessara Baldi Kerry A Mullaney Hikmat Al-Ahmadie Efsevia Vakiani Adam A Abeshouse Alexander V Penson Philip Jonsson Niedzica Camacho Matthew T Chang Helen H Won Benjamin E Gross Ritika Kundra Zachary J Heins Hsiao-Wei Chen Sarah Phillips Hongxin Zhang Jiaojiao Wang Angelica Ochoa Jonathan Wills Michael Eubank Stacy B Thomas Stuart M Gardos Dalicia N Reales Jesse Galle Robert Durany Roy Cambria Wassim Abida Andrea Cercek Darren R Feldman Mrinal M Gounder A Ari Hakimi James J Harding Gopa Iyer Yelena Y Janjigian Emmet J Jordan Ciara M Kelly Maeve A Lowery Luc G T Morris Antonio M Omuro Nitya Raj Pedram Razavi Alexander N Shoushtari Neerav Shukla Tara E Soumerai Anna M Varghese Rona Yaeger Jonathan Coleman Bernard Bochner Gregory J Riely Leonard B Saltz Howard I Scher Paul J Sabbatini Mark E Robson David S Klimstra Barry S Taylor Jose Baselga Nikolaus Schultz David M Hyman Maria E Arcila David B Solit Marc Ladanyi Michael F Berger

Nat Med 2017 08;23(8):1004

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm0817-1004cDOI Listing
August 2017

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

Authors:
Ahmet Zehir Ryma Benayed Ronak H Shah Aijazuddin Syed Sumit Middha Hyunjae R Kim Preethi Srinivasan Jianjiong Gao Debyani Chakravarty Sean M Devlin Matthew D Hellmann David A Barron Alison M Schram Meera Hameed Snjezana Dogan Dara S Ross Jaclyn F Hechtman Deborah F DeLair JinJuan Yao Diana L Mandelker Donavan T Cheng Raghu Chandramohan Abhinita S Mohanty Ryan N Ptashkin Gowtham Jayakumaran Meera Prasad Mustafa H Syed Anoop Balakrishnan Rema Zhen Y Liu Khedoudja Nafa Laetitia Borsu Justyna Sadowska Jacklyn Casanova Ruben Bacares Iwona J Kiecka Anna Razumova Julie B Son Lisa Stewart Tessara Baldi Kerry A Mullaney Hikmat Al-Ahmadie Efsevia Vakiani Adam A Abeshouse Alexander V Penson Philip Jonsson Niedzica Camacho Matthew T Chang Helen H Won Benjamin E Gross Ritika Kundra Zachary J Heins Hsiao-Wei Chen Sarah Phillips Hongxin Zhang Jiaojiao Wang Angelica Ochoa Jonathan Wills Michael Eubank Stacy B Thomas Stuart M Gardos Dalicia N Reales Jesse Galle Robert Durany Roy Cambria Wassim Abida Andrea Cercek Darren R Feldman Mrinal M Gounder A Ari Hakimi James J Harding Gopa Iyer Yelena Y Janjigian Emmet J Jordan Ciara M Kelly Maeve A Lowery Luc G T Morris Antonio M Omuro Nitya Raj Pedram Razavi Alexander N Shoushtari Neerav Shukla Tara E Soumerai Anna M Varghese Rona Yaeger Jonathan Coleman Bernard Bochner Gregory J Riely Leonard B Saltz Howard I Scher Paul J Sabbatini Mark E Robson David S Klimstra Barry S Taylor Jose Baselga Nikolaus Schultz David M Hyman Maria E Arcila David B Solit Marc Ladanyi Michael F Berger

Nat Med 2017 Jun 8;23(6):703-713. Epub 2017 May 8.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/nm.4333
Publisher Site
http://dx.doi.org/10.1038/nm.4333DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461196PMC
June 2017

Cisplatin Therapy Does Not Worsen Renal Function in Severe Antenatal Bartter Syndrome.

Case Rep Nephrol Dial 2017 May-Aug;7(2):49-54. Epub 2017 May 8.

cGenitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000475838DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465520PMC
May 2017

Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.

J Clin Oncol 2017 Apr 27;35(11):1211-1222. Epub 2017 Feb 27.

Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women's Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Robert J. Hamilton, Princess Margaret Cancer Center, Toronto, Ontario; Christian K. Kollmannsberger, University of British Columbia, Vancouver, British Columbia, Canada; David J. Vaughn, University of Pennsylvania, Philadelphia, PA; Steve E. Lipshultz, Wayne State University School of Medicine; Steve E. Lipshultz, Children's Hospital of Michigan; Steve E. Lipshultz, Karmanos Cancer Institute, Detroit, MI; and Sophie D. Fossa, Oslo University Hospital, Radium Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.3108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455601PMC
April 2017

Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.

J Urol 2017 02 5;197(2):391-397. Epub 2016 Oct 5.

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.09.113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241176PMC
February 2017

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.

J Clin Oncol 2017 02 14;35(6):591-597. Epub 2016 Nov 14.

Toni K. Choueiri and Meghara K. Walsh, Dana-Farber Cancer Institute; M. Dror Michaelson, Massachusetts General Hospital Cancer Center, Boston, MA; Susan Halabi and Ben L. Sanford, Alliance Statistics and Data Center and Duke University; Daniel J. George, Duke Cancer Institute, Duke University Medical Center, Durham, NC; Olwen Hahn, Alliance Protocol Operations Office, Chicago, IL; Darren R. Feldman and Michael J. Morris, Memorial Sloan Kettering Cancer Center, New York, NY; Thomas Olencki, Ohio State University Medical Center, Columbus, OH; Joel Picus, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO; Eric J. Small, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; and Shaker Dakhil, University of Kansas Wichita, Wichita, KS.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.7398DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455807PMC
February 2017

Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis.

Eur Urol 2016 12 13;70(6):1082-1083. Epub 2016 Jun 13.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.05.040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615055PMC
December 2016

Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma.

J Clin Oncol 2016 11;34(32):3846-3853

Martin H. Voss, Ying-Bei Chen, Kaitlin M. Woo, Joshua L. Chaim, Devyn T. Coskey, Almedina Redzematovic, Patricia Wang, William Lee, S. Duygu Selcuklu, Chung-Han Lee, Michael F. Berger, Satish K. Tickoo, Victor E. Reuter, Sujata Pati, James J. Hsieh, Robert J. Motzer, and Darren R. Feldman, Memorial Sloan Kettering Cancer Center; and Ana M. Molina, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.9084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791841PMC
November 2016

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.

J Clin Oncol 2016 11 30;34(33):4000-4007. Epub 2016 Sep 30.

Aditya Bagrodia, Byron H. Lee, William Lee, Eugene K. Cha, Gopa Iyer, Eugene J. Pietzak, Sizhi Paul Gao, Emily C. Zabor, Irina Ostrovnaya, Samuel D. Kaffenberger, Aijazuddin Syed, Maria E. Arcila, Raju S. Chaganti, Ritika Kundra, Jana Eng, Joseph Hreiki, Michael F. Berger, Dean F. Bajorin, Manjit S. Bains, Nikolaus Schultz, Victor E. Reuter, Joel Sheinfeld, George J. Bosl, Hikmat A. Al-Ahmadie, David B. Solit, Darren R. Feldman, Memorial Sloan Kettering Cancer Center; John P. Sfakianos, Icahn School of Medicine at Mount Sinai; Gopa Iyer, Michael F. Berger, Dean F. Bajorin, Manjit S. Bains, Victor E. Reuter, Joel Sheinfeld, George J. Bosl, Hikmat A. Al-Ahmadie, David B. Solit, Darren R. Feldman, Weill Cornell Medical College; and Vladimir Vacic, Kanika Arora, Dayna M. Oschwald, New York Genome Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.7798DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477828PMC
November 2016

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.

J Clin Oncol 2016 08 27;34(23):2712-20. Epub 2016 Jun 27.

Robert D. Frisina, University of South Florida, Tampa, FL; Heather E. Wheeler, Loyola University Chicago; M. Eileen Dolan, University of Chicago, Chicago, IL; Sophie D. Fossa, Oslo University Hospital, Radiumhospital, Oslo, Norway; Sarah L. Kerns, Chunkit Fung, and Eileen M. Johnson, J.P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester; Darren R. Feldman and Amy Budnick, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women's Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick O. Monahan, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Robert Hamilton, Princess Margaret Cancer Centre, Toronto, ON; David J. Vaughn, University of Pennsylvania, Philadelphia, PA; and Steven E. Lipshultz, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.66.8822
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.66.8822DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019759PMC
August 2016

Are Some Cases of Somatic Type Malignancy Potentially Avoidable?

J Urol 2016 07 13;196(1):11-3. Epub 2016 Apr 13.

Genitourinary Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.04.044DOI Listing
July 2016

Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors.

J Clin Oncol 2016 07 16;34(21):2478-83. Epub 2016 May 16.

Darren R. Feldman, Kristina Lim, Sujata Patil, Kaitlin M. Woo, Maryann Carousso, Amanda Hughes, Joel Sheinfeld, Manjit Bains, Dean F. Bajorin, George J. Bosl, and Robert J. Motzer, Memorial Sloan Kettering Cancer Center; Darren R. Feldman, Dean F. Bajorin, George J. Bosl, and Robert J. Motzer, Weill Medical College of Cornell University, New York, NY; and James Hu, Tanya B. Dorff, Siamak Daneshmand, Charlene Ketchens, and David I. Quinn, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.7899DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320896PMC
July 2016

The Management of Advanced Germ Cell Tumors in 2016: The Memorial Sloan Kettering Approach.

Oncology (Williston Park) 2016 Jul;30(7):653-64

View Article

Download full-text PDF

Source
July 2016

Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs.

Clin Genitourin Cancer 2016 Feb 7;14(1):56-62. Epub 2015 Aug 7.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.07.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965701PMC
February 2016

Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options--An Analysis From the Global Germ Cell Cancer Group.

J Clin Oncol 2016 Feb 12;34(4):345-51. Epub 2015 Oct 12.

Darren R. Feldman, Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY; Anja Lorch, University Hospital Düsseldorf, Düsseldorf; Carsten Bokemeyer, University Hospital Eppendorf, Hamburg, Germany; Andrew Kramar, Centre Oscar Lambret, Lille; Aude Flechon and Helen Boyle, Centre Léon Bérard, Lyon, France; Costantine Albany and Lawrence H. Einhorn, Indiana University, Bloomington, IN; Patrizia Giannatempo and Andrea Necchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milano; Teodoro Sava, Azienda Ospedaliera Universitaria Integrata di Verona, Verona; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Istituto di Ricovero e Cura a Carattere Scientifico, Meldola, Italy; Peter Chung, Princess Margaret Cancer Centre, University of Toronto, Toronto; Eric William Winquist, London Health Sciences Center, London, Ontario, Canada; Robert A. Huddart, Royal Marsden Hospital; Thomas Powles, St Bartholomew's Hospital, London, United Kingdom; Alexey Tryakin, Blokhin's Russian Cancer Research Center, Moscow, Russia; Jorge Aparicio, University Hospital Le Fe, Valencia, Spain; Christopher J. Sweeney, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Gabriella Cohn Cedermark, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden; and Jörg Beyer, UniversitätsSpital Zürich, Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.62.7000
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.7000DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070579PMC
February 2016

Risk of Vascular Toxicity with Platinum Based Chemotherapy in Elderly Patients with Bladder Cancer.

J Urol 2016 Jan 1;195(1):33-40. Epub 2015 Sep 1.

Cardiology Service, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00225347150470
Publisher Site
http://dx.doi.org/10.1016/j.juro.2015.08.088DOI Listing
January 2016

Development of a risk stratification system to guide treatment for female germ cell tumors.

Gynecol Oncol 2015 Sep 24;138(3):566-72. Epub 2015 Jun 24.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258153005
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2015.06.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012648PMC
September 2015

Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration.

J Clin Oncol 2015 Sep 24;33(27):3018-28. Epub 2015 Aug 24.

Thomas A. Olson, Emory University, Atlanta, GA; Matthew J. Murray and James C. Nicholson, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, United Kingdom; Carlos Rodriguez-Galindo and A. Lindsay Frazier, Boston Children's Hospital, Boston; Carlos Rodriguez-Galindo, A. Lindsay Frazier, and Christopher Sweeney, Dana-Farber Cancer Institute, Boston, MA; Deborah F. Billmore, Riley Hospital for Sick Children, Indianapolis, IN; Mark D. Krailo and Ha M. Dang, University of Southern California, Los Angeles, CA; James F. Amatruda, University of Texas Southwestern Medical Center and Children's Medical Center, Dallas; David M. Gershenson, University of Texas MD Anderson Cancer Center, Houston, TX; Claire M. Thornton, Royal Victoria Hospital, Belfast, United Kingdom; G. Suren Arul, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, United Kingdom; Sara J. Stoneham, University College London Hospitals NHS Foundation Trust, London, United Kingdom; Farzana Pashankar, Yale University School of Medicine, New Haven, CT; Daniel Stark, University of Leeds, Leeds, United Kingdom; Furqan Shaikh, The Hospital for Sick Children, Toronto; Allan Covens, University of Toronto, Toronto, Ontario, Canada; Jean Hurteau, University of Chicago Pritzker School of Medicine, Chicago, IL; Sally P. Stenning, Medical Research Council, London, United Kingdom; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Peter S. Grimison, Sydney Cancer Center, Sydney, New South Wales, Australia; Robert A. Huddart, Institute of Cancer Research and Royal Marsden Hospital, Surrey, United Kingdom; Thomas Powles, Barts Cancer Institute, London, United Kingdom; Luiz Fernando Lopes, Barretos Pediatric Cancer Center, São Paulo, Brazil; Simone dos Santos Agular, Centro Infantil Boldrini, Campinas, Brazil; Girish Chinnaswamy, Tata Memorial Hospital, Mumbai, India; Sahar Khaleel and Sherif Abouelnaga, Children's Cancer Hospital, Cairo, Egypt; and Jul

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.5337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979195PMC
September 2015

Salvage high-dose chemotherapy for germ cell tumors.

Urol Oncol 2015 Aug 30;33(8):355-62. Epub 2015 Mar 30.

Barts Cancer Institute, Queen Mary University of London, St Bartholomew's Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2015.01.025DOI Listing
August 2015

Late Relapse of Testicular Germ Cell Tumors.

Urol Clin North Am 2015 Aug 16;42(3):359-68. Epub 2015 Jun 16.

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 353 East 68th Street, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2015.04.010DOI Listing
August 2015

Reply to L.C. Pagliaro et al.

Authors:
Darren R Feldman

J Clin Oncol 2015 Jul 1;33(20):2327-8. Epub 2015 Jun 1.

Memorial Sloan Kettering Cancer Center; and Weill Medical College of Cornell University, New York, NY

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.60.9339DOI Listing
July 2015

Follow-Up Management of Patients With Testicular Cancer: A Multidisciplinary Consensus-Based Approach.

J Natl Compr Canc Netw 2015 Jun;13(6):811-22

From Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Division of Medical Oncology, Moffitt Cancer Center, Tampa, Florida; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Division of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Division of Oncology, Stanford University Medical Center, Palo Alto, California; Division of Hematology/Oncology, The University of California, San Francisco, California; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0094DOI Listing
June 2015

Update in germ cell tumours.

Authors:
Darren R Feldman

Curr Opin Oncol 2015 May;27(3):177-84

aGenitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center bDepartment of Medicine, Weill Medical College of Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000179DOI Listing
May 2015

Microwave ablation (MWA) for the treatment of a solitary, chemorefractory testicular cancer liver metastasis.

Cardiovasc Intervent Radiol 2015 Apr 18;38(2):488-93. Epub 2014 Jun 18.

Department of Radiology, Weill-Cornell Medical College, Interventional Radiology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00270-014-0924-zDOI Listing
April 2015

Safety and efficacy of targeted therapy for renal cell carcinoma with brain metastasis.

Clin Genitourin Cancer 2015 Feb 8;13(1):59-66. Epub 2014 Jun 8.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.06.002DOI Listing
February 2015

Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.

J Urol 2015 Feb 20;193(2):513-8. Epub 2014 Aug 20.

Urology Service, Department of Surgery, and the Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://ac.els-cdn.com/S0022534714042542/1-s2.0-S002253471404
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S002253471404254
Publisher Site
http://dx.doi.org/10.1016/j.juro.2014.08.081DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354932PMC
February 2015

Treatment options for stage I nonseminoma.

Authors:
Darren R Feldman

J Clin Oncol 2014 Dec 3;32(34):3797-800. Epub 2014 Nov 3.

Memorial Sloan Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.8006DOI Listing
December 2014

Editorial comment.

Urology 2014 Oct;84(4):890-1

Genitourinary Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2014.05.056DOI Listing
October 2014

Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors.

Clin Cancer Res 2014 Jul 8;20(14):3712-20. Epub 2014 May 8.

Authors' Affiliations: Genitourinary Oncology Service, Department of Medicine; Human Oncology and Pathogenesis Program; Departments of Department of Medicine, Weill Medical College of Cornell University; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2868DOI Listing
July 2014

The role of high-dose chemotherapy in the management of germ cell tumors.

Curr Opin Oncol 2014 May;26(3):284-93

aGenitourinary Oncology, Oncology Center, Hospital Sirio-Libanes, Sao Paulo, Brazil bGenitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center cDepartment of Medicine, Weill Medical College of Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000070DOI Listing
May 2014

Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.

J Natl Cancer Inst 2014 Mar 12;106(5). Epub 2014 Mar 12.

Affiliations of authors: Rubin Center for Cancer Survivorship and Department of Radiation Oncology (LBT) and Department of Neurology (DNH), University of Rochester Medical Center, Rochester, NY; Department of Oncology, Oslo University Hospital, Radiumhospital, Oslo, Norway (SDF); Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (HDS); Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA (CJB); Department of Chemical and Biomedical Engineering, University of South Florida, Tampa, FL (RDF); Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY (DRF); Department of Genitourinary Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX (LCP); Department of Radiation Oncology, Mayo Clinic, Rochester, MN (RCM); Department of Medicine, University of Pennsylvania, Philadelphia, PA (DJV); Department of Medical Oncology, Indiana University, Indianapolis, IN (LHE); Departments of Human Genetics (NJC) and Medicine (MED), University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568989PMC
March 2014

Long-term mortality in patients with germ cell tumors: effect of primary cancer site on cause of death.

Urol Oncol 2014 Jan 12;32(1):26.e9-15. Epub 2013 Feb 12.

Department of Urology, University of Minnesota, Minneapolis, MN.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439120033
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2012.09.003DOI Listing
January 2014

Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors.

Int J Dev Biol 2013 ;57(2-4):273-80

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1387/ijdb.130135mbDOI Listing
January 2014

Long-term response to sunitinib therapy for metastatic renal cell carcinoma.

Clin Genitourin Cancer 2013 Sep 24;11(3):297-302. Epub 2013 May 24.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2013.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959735PMC
September 2013

Fertility preservation strategies for male patients with cancer.

Nat Rev Urol 2013 Aug 9;10(8):463-72. Epub 2013 Jul 9.

Male Sexual and Reproductive Medicine Program, Memorial Sloan-Kettering Cancer Center, Urology Service, Department of Surgery, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2013.145DOI Listing
August 2013

Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older.

Cancer 2013 Jul 19;119(14):2574-81. Epub 2013 Apr 19.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28025DOI Listing
July 2013

The conundrum of clinical trials in adult germ-cell tumours.

Lancet Oncol 2013 Jan;14(1):14-5

Barts Cancer Institute, Queen Mary University of London, St Bartholomew's Hospital, London EC1A 7BE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(12)70561-2DOI Listing
January 2013

Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors.

Cancer 2012 Oct 21;118(20):5078-83. Epub 2012 Mar 21.

Department of Medicine, Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10022, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27505DOI Listing
October 2012

The risk of hand foot skin reaction to pazopanib, a novel multikinase inhibitor: a systematic review of literature and meta-analysis.

Invest New Drugs 2012 Aug 11;30(4):1773-81. Epub 2011 Mar 11.

Dermatology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Rockefeller Outpatient Pavilion Suite 228, 160 East 53rd Street, New York, NY 10022, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-011-9652-2DOI Listing
August 2012

Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site.

Urology 2012 May 23;79(5):1079-84. Epub 2012 Mar 23.

Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2011.11.090DOI Listing
May 2012

Late cardiovascular toxicity following chemotherapy for germ cell tumors.

J Natl Compr Canc Netw 2012 Apr;10(4):537-44

Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2012.0051DOI Listing
April 2012

Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma.

Invest New Drugs 2012 Feb 14;30(1):335-40. Epub 2010 Aug 14.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-010-9491-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257373PMC
February 2012

Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease.

Am J Clin Oncol 2011 Oct;34(5):454-9

Department of Medicine, Genitourinary Oncology Service, Weil Medical College of Cornell University, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e3181f47aa4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661202PMC
October 2011

High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis.

J Clin Oncol 2011 Sep 1;29(25):3466-73. Epub 2011 Aug 1.

Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H709, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.35.5669DOI Listing
September 2011

Is high dose therapy superior to conventional dose therapy as initial treatment for relapsed germ cell tumors? The TIGER Trial.

J Cancer 2011 1;2:374-7. Epub 2011 Jul 1.

Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133961PMC
July 2011

High-dose chemotherapy and stem cell transplantation for advanced testicular cancer.

Expert Rev Anticancer Ther 2011 Jul;11(7):1091-103

Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.10.231DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253700PMC
July 2011

A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.

Hematol Oncol Clin North Am 2011 Jun 22;25(3):557-76, viii -ix. Epub 2011 Apr 22.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S088985881100032
Publisher Site
http://dx.doi.org/10.1016/j.hoc.2011.03.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230321PMC
June 2011

Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an update.

Urology 2011 Mar;77(3):655-9

Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009042951001828
Publisher Site
http://dx.doi.org/10.1016/j.urology.2010.10.002DOI Listing
March 2011

Contemporary lymph node counts during primary retroperitoneal lymph node dissection.

Urology 2011 Feb 15;77(2):368-72. Epub 2010 Dec 15.

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2010.05.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012337PMC
February 2011

The approach to the patient with synchronous bilateral germ cell tumors: a lesson in oncologic prioritization.

Authors:
Darren R Feldman

Oncology (Williston Park) 2010 Jul;24(8):761-3

Genitourinary Oncology Service, Division of Solid Tumors, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
July 2010

TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis.

J Clin Oncol 2010 Apr 1;28(10):1706-13. Epub 2010 Mar 1.

Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.1561DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651604PMC
April 2010